Summary
Latest filing:
Willis C. Lee is CEO, Director of Emmaus Life Sciences, Inc. (EMMA). 1 SEC Form 4 filing on record, dated 2 September 2026. Most recent open-market trade: bought $5K of EMMA on 2 September 2026. Lifetime open-market purchases: $18K.
Recent Transactions
6Every recent SEC Form 4 transaction Willis C. Lee has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Willis C. Lee's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $63.45M of SEPN open-market activity in the last 12 months
- BVF PARTNERS L P - $62.96M of MLTX open-market activity in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M of STAA open-market activity in the last 12 months
- Jonathan M. Rothberg - $62.19M of BFLY open-market activity in the last 12 months
- L1 Capital Pty Ltd - $60.97M of AVR open-market activity in the last 12 months
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Willis C. Lee?
Willis C. Lee is a corporate insider, tracked as CEO, Director of Emmaus Life Sciences, Inc. (EMMA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Willis C. Lee submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Willis C. Lee been buying or selling stock?
Recorded transactions: 6 open-market purchases ($18K) and 0 open-market sales across all tracked filings.
Where can I see all of Willis C. Lee's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Willis C. Lee and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
